Wed, 03rd Feb 2016 11:18
LONDON (Alliance News) - UK-based stem cell therapy company ReNeuron Group PLC Wednesday said Chairman John Berriman bought 318,476 shares at a price of 3.14 pence per share on Tuesday.
Following this transaction, Berriman holds 1 million shares which represents a 0.033% stake in the company.
The stock was up 8.3% at 3.25p Wednesday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
ReNeuron Group PLC - Brigdend, Wales-based stem cell and exosomes technology company - Says Mark Smith and Stephen Cork of Cork Gully LLP, joint admin...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued last week Wednesday and not separately reported by Allianc...
(Alliance News) - ReNeuron Group PLC on Wednesday announced Chief Financial Officer John Hawkins will be stepping down from his role on May 7.
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Reneuron (RENE)